Use of ATP analogs to inhibit HIV-1 transcription

Authors

Aarthi Narayanan, George Mason University
Gavin Sampey, George Mason University
Rachel Van Duyne, George Washington University
Irene Guendel, George Mason University
Kylene Kehn-Hall, George Mason University
Jessica Roman, George Mason UniversityFollow
Robert Currer, George Mason University
Herve Galons, Université Paris - Descartes, Paris, France
Nassima Oumata, Université Paris - Descartes, Paris, France
Benoit Joseph, Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, Villeurbanne, France
Laurent Meijer, Station Biologique, Bretagne, France
Massimo Caputi, Florida Atlantic University
Sergei Nekhai, Howard University
Fatah Kashanchi, George Mason University

Document Type

Journal Article

Publication Date

10-10-2012

Journal

Virology

Volume

Volume 432, Issue 1

Inclusive Pages

219-231

Keywords

Adenosine Triphosphate--analogs & derivatives; Adenosine Triphosphate--metabolism; Antiviral Agents--metabolism; HIV-1--drug effects; HIV-1--physiology; Purines--metabolism; Pyridines--metabolism; Transcription; Genetic--drug effects

Comments

This is a PubMed Central article. Click on link for full-text access.

APA Citation

Narayanan, A., Sampey, G., Van Duyne, R., Guendel, I., Kehn-Hall, K., Roman, J., Currer, R., Galons, H., Oumata, N., Joseph, B., Meijer, L., Caputi, M., Nekhai, S., Kashanchi, F. (2012). Use of ATP analogs to inhibit HIV-1 transcription. Virology, 432(1), 219-231.

Peer Reviewed

1

Open Access

1